Leaving BNY Website

 

You are leaving the BNY Mellon's Depositary Receipts' Website.
Linked sites are not under the control of The Bank of New York Mellon Corporation or any of its subsidiaries or affiliates (together, the "Company") and the Company is not responsible for the content of any linked site or any link contained in a linked site. If you choose to link to a website not controlled by the Company, you do so entirely at your own risk and the Company makes no warranties, either express or implied, concerning the content of such site, including the accuracy, completeness, reliability or suitability thereof for any particular purpose, nor does the Company warrant that such site or content is free from any claims of copyright, trademark or other infringement of the rights of third parties or that such site or content is devoid of viruses or other contamination. The Company does not guarantee the authenticity of documents on the Internet. Links to other sites do not imply any endorsement of or responsibility for the opinions, ideas, products, information or services offered at such sites, or any representation regarding the content at such sites. The Company reserves the right to terminate any link at any time.

Do you wish to continue to the linked site on these terms?

Stay On Page
Leave Page

© 2025 The Bank of New York Mellon Corporation

Depositary Receipt business and services are conducted through The Bank of New York Mellon.

BNY - DR Legal Disclaimer
  

To learn more about DRs, please contact DRBrokerSolutions@bny.com.

 

The information and data provided herein are provided for general informational purposes only.  BNY does not warrant or guarantee the accuracy, timeliness or completeness of any such information or data.  BNY does not undertake any obligation to update or amend any information or data, and may change, update or amend any information or data at any time without prior notice.

 

BNY provides no advice, recommendation or endorsement with respect to any company or securities.  No information or data is intended to provide legal, tax, accounting, investment, financial, trading or other advice on any matter, and is not to be used as such.  We expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon any information or data, including market value loss on the sale or purchase of securities or other instruments or obligations.

 

Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.

 

BNY collects fees from DR holders pursuant to the terms and conditions of the DRs and any deposit agreement under which they are issued.  From time to time, BNY may make payments to an issuer to reimburse and/or share revenue from the fees collected from DR holders, or waive fees and expenses to an issuer for services provided, generally related to costs and expenses arising out of establishment and maintenance of the DR program.  BNY may pay a rebate to brokers in connection with unsponsored DR issuances; brokers may or may not disclose or pass back some or all of such rebate to the DR investor.  BNY may also use brokers, dealers or other service providers that are affiliates and that may earn or share fees and commissions.

 

BNY may execute DR foreign currency transactions itself or through its affiliates, or the Custodian or the underlying Company may execute foreign currency transactions and pay US dollars to BNY.  In those instances where it executes DR foreign currency transactions itself or through its affiliates, BNY acts as principal counterparty and not as agent, advisor, broker or fiduciary.  In such cases, BNY  has no obligation to obtain the most favorable exchange rate, makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate. BNY earns and retains revenue on its executed foreign currency transactions based on, among other things, the difference between the rate it assigns to the transaction and the rate that it pays and receives for purchases and sales of currencies when buying or selling foreign currency for its own account.  The methodology used by BNY to determine DR conversion rates is available to registered Owners upon request or can be accessed here.  In those instances where BNY's Custodian executes DR foreign currency transactions, the Custodian has no obligation to obtain the most favorable exchange rate or that the method by which the rate will be determined will be the most favorable rate, and BNY makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate.  In certain instances, BNY may receive dividends and other distributions from an issuer of securities underlying DRs in U.S. dollars rather than in a foreign currency.  In such cases, BNY will not engage in or be responsible for any foreign currency transactions and it makes no representation that the rate obtained by an issuer is a favorable rate and it will not be liable for any direct or indirect losses associated with the rate.

 

BNY is a global investments company dedicated to helping its clients manage and service their financial assets throughout the investment lifecycle.  BNY is the corporate brand of The Bank of New York Mellon Corporation (NYSE: BK).

 

BNY's name, brand and/or trademarks may not be used, copied or reproduced without the prior express written consent of BNY.

 

DEPOSITARY RECEIPTS ARE NOT INSURED BY THE FDIC OR ANY OTHER GOVERNMENT AGENCY, ARE NOT DEPOSITS OR OTHER OBLIGATIONS OF, AND ARE NOT GUARANTEED BY, BNY AND ARE SUBJECT TO INVESTMENT RISKS INCLUDING POSSIBLE LOSS OF PRINCIPAL AMOUNT INVESTED.

 

Please also see "Terms of Use."

ACCEPT

Please enable cookies in your browser if you wish to proceed.

Regulation S Disclaimer

 

Access To This Company Profile Is Restricted To Non-U.S. Persons Outside The United States Within The Meaning Of Regulation S Under The U.S. Securities Act Of 1933, As Amended (The "Securities Act").1

 

This company profile does not constitute an offer to sell or the solicitation of an offer to buy any securities in any jurisdiction or under any circumstances in which such offer or solicitation is unlawful.

 

Each person accessing this company profile, by so doing, will be deemed to have acknowledged that: (1) It is not a U.S. person (within the meaning of Regulation S under the Securities Act) and is located outside the U.S. (within the meaning of Regulation S under the Securities Act); and (2) Any securities described herein (A) have not been and will not be registered under the Securities Act or with any securities regulatory authority of any state or other jurisdiction and (B) may not be offered, sold, pledged or otherwise transferred except to persons outside the U.S. in accordance with Regulation S under the Securities Act pursuant to the terms of such securities.

 

If you agree with and accept the foregoing and the Terms of use governing this site, please select "Accept" below. Otherwise, press "Decline" to return to the previous page.

 

1 As defined in the Securities Act, the term "U.S Person" means: (1) any natural person resident in the United States; (2) any partnership or corporation organized or incorporated under the laws of the United States; (3) any estate of which any executor or administrator is a U.S. person; (4) any trust of which any trustee is a U.S. person; (5) any agency or branch of a foreign entity located in the United States; (6) any non-discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary for the benefit or account of a U.S. person; (7) any discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary organized, incorporated, or (if an individual) resident in the United States; and (8) any partnership or corporation if: (A) organized or incorporated under the laws of any foreign jurisdiction; and (B) formed by a U.S. person principally for the purpose of investing in securities not registered under the Securities Act, unless it is organized or incorporated, and owned, by accredited investors (as defined in Rule 501(a)) who are not natural persons, estates or trusts.

I Accept Decline

© 2024 The Bank of New York Mellon Corporation
Depositary Receipt business and services are conducted through The Bank of New York Mellon.

Back to Daily DR Market Summary

StreetAccount Summary - Europe Pre-Open: FTSE (0.2%), DAX (0.5%), CAC (0.4%), MIB (0.7%), IBEX (0.3%)

Apr 07 ,2026

  • Synopsis

    • European equity markets set to open broadly lower following the long Easter weekend. Oil higher, with WTI Crude +2.93% to $115.70; Brent Crude +1.5% to $111.45.

    • President Trump told reporters the Tuesday deadline set for Iran to make a deal is final and unlikely to be extended (Reuters). Noted Iran's proposal was significant but not good enough. At the scheduled press conference, threatened permanent damage to Iran's power plants and bridges in a matter of hours (Reuters). A Reuters source separately indicated the 45-day ceasefire plan reported yesterday by Axios that would come into effect immediately has been presented to both sides. Tehran still rejecting a ceasefire, instead demanding a permanent end to the war. IRNA reported Iran's response consisted of 10 clauses including an end to conflict in the region, protocol for safe passage through the Strait of Hormuz, lifting sanctions and reimbursement for reconstruction. Latest Axios report only reaffirmed two sides remained far apart as a US official described Iran's response as "maximalist." Article added Israeli Prime Minister Netanyahu said to be opposed to a ceasefire deal. Bloomberg noted more mixed signals from Trump, who emphasized reopening the Strait remains a priority after prior comments from the administration about whether this was a condition for withdrawal. Trump also mixed threats with an upbeat assessment of diplomatic conversations, despite Iran's response via state media.

    • European macro data releases out today include Italy, Spain Mar services PMI as well as final reads for Eurozone, France, Germany, UK, Sweden Mar preliminary CPI, Austria Feb PPI

    • Elsewhere, Bank of France hosts ECB Governing Council's annual retreat (through Wed). U.S. Vice President JD Vance scheduled to visit Hungary (through Wed). EU's von der Leyen receives the Lower Saxony Land Medal and delivers a speech whilst EU's Albuquerque participates online at the Senior Global Financial Leaders Meeting.

  • Politics/Macro/World News

    • UK to host meeting on safe passage through Strait of Hormuz after war -- FT

    • Trump's Hormuz deadline looms but Asian nations have already struck deals with Iran -- BBC

    • Inflation scars risk quickly lifting expectations; ECB must be ready to act: ECB policymaker Dimitar Radev -- Reuters

    • UK new car sales grew 6% in March, industry data shows -- Reuters

    • Italian central bank lowers growth forecasts -- link

    • Italy Deficit at 3.1% Breaches EU Ceiling in Setback for Meloni -- Bloomberg

    • Brussels banking rules could hit lenders and UK-EU 'reset', City figures warn -- FT

    • UK considers testing AI models used by banks -- FT

  • Top company news

    • Earnings/updates

      • EMSN.SW (EMS-Chemie Holding) -- reports Q1 sales CHF487M vs FactSet CHF491M (1 estimate)

      • GNFT.FP (GENFIT) -- reports FY net income (€86.0M) vs FactSet (€7.0M) [5 est, (€27.8)-19.2M]

      • CYAD.BB (Celyad Oncology) -- reports FY net income €0.8M vs year-ago (€5.8M)

      • APAM.NA (Aperam) -- provides update on Q1 outlook

      • Also reporting today

        • Earnings:

          • DACHs: bet-at-home.com (ACX.GR)

          • UK: JTC (JTC.LN), Jubilee Metals Group (JLP.LN)

        • Trading Update:

          • Benelux: Nedap (NEDAP.NA)

        • Sales: Avanza Bank Holding (AZA.SS), Nordnet (SAVE.SS), flatexDEGIRO (FTK.GR)

        • CMD/Events: OSE Immunotherapeutics (OSE.FP), GEA Group (G1A.GR) pre-close call at 14:00CET

    • M&A

      • BVI.FP (Bureau Veritas) -- acquires Lotusworks at enterprise value of €375M

      • ULVR.LN (Unilever) -- to pursue more health and wellness acquisitions - London Times

      • 5.HK (HSBC Holdings) -- launches sale process for Australian loan book (again) - The Australian

      • YOU.LN (YouGov) -- Activist Gatemore Capital urges YouGov to cut costs more aggressively and be open to selling consumer panels business for less than £270M paid two years ago - London Times

      • IPN.FP (Ipsen) -- AMF grants 26% holder Beech Tree exemption from requirement to make public tender offer for all Ipsen shares

    • Healthcare

      • SAN.FP (Sanofi) -- Sanofi's lunsekimig met primary and key secondary endpoints in phase 2 respiratory studies in asthma and CRSwNP

      • CSL.AU (CSL) -- notes U.S. recent section 232 tariffs on pharmaceuticals, expects most of its U.S. product sales will not be subject to tariffs

      • EVT.GR (Evotec) -- SEC filing: SCHEDULE 13D/A (Filed by MAK Capital Fund LP)

      • EVT.GR (Evotec) -- 7% holder MAK Capital Fund LP discloses 2-Apr letter to management and board; reiterates seeking separation of Just Biologics and pursuit of carve-out IPO - 13D/A

      • RADX (Radiopharm Theranostics) -- Radiopharm Theranostics, Siemens Healthineers sign supply agreement in which Siemens Healthineers will radiolabel and distribute RAD101 with Fluorine-18

    • Other

      • LI.FP (Klepierre) -- appoints Stanley Shashoua as Chairman of the Supervisory board

      • HSBA.LN (HSBC Holdings) -- HSBC could be lining up George Meddings as its next chair - Sky News

      • Crypto assets and miners higher in the past week with Bitcoin trading near $70K (6-Apr)

  • Key rating changes

    • Upgrades

      • ANTO.LN (Antofagasta) -- to reduce from sell at Peel Hunt

      • EVO.SS (Evolution) -- to buy from hold at Pareto

      • YAR.NO (Yara International) -- to buy from hold at Pareto

    • Downgrades

      • COLR.BB (Colruyt Group) -- to neutral from buy at UBS

      • ADDT.B.SS (Addtech) -- to hold from buy at DNB Carnegie

      • N91.LN (Ninety One) -- to neutral from buy at BofA

  • Data

    • Nikkei (0.06%) to 53381.69

    • Hang Seng +0.00% to 25116.53

    • Shanghai Composite +0.12% to 3884.65

    • S&P futures (31.3) vs prior close of 6651.0

    • €-$ (0.0010) or (0.09%) to 1.1534

    • $-¥ +0.13 or +0.08% to 159.81

    • €-¥ (0.02) or (0.01%) to 184.30

This information and data is provided for general informational purposes only. The Bank of New York Mellon and our information suppliers do not warrant or guarantee the accuracy, timeliness or completeness of this information or data. We provide no advice nor recommendation or endorsement with respect to any company or securities. We do not undertake any obligation to update or amend this information or data. Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.
Please refer to "Terms Of Use".

DEPOSITARY RECEIPTS:
NOT FDIC, STATE OR FEDERAL AGENCY INSURED
MAY LOSE VALUE
NO BANK, STATE OR FEDERAL AGENCY GUARANTEE

    • BNY.com Terms of Use Privacy Cookie Notice Manage Cookies Disclaimer CUSIP Disclaimer

    • ©  2025 The Bank of New York Corporation. Depositary Receipt business and services are conducted through The Bank of New York.